Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Current Leases (2019 - 2025)

BioCorRx's Current Leases history spans 7 years, with the latest figure at $41686.0 for Q3 2025.

  • For Q3 2025, Current Leases rose 6.16% year-over-year to $41686.0; the TTM value through Sep 2025 reached $41686.0, up 6.16%, while the annual FY2024 figure was $40057.0, 67.36% down from the prior year.
  • Current Leases for Q3 2025 was $41686.0 at BioCorRx, roughly flat from $41686.0 in the prior quarter.
  • Across five years, Current Leases topped out at $146187.0 in Q3 2023 and bottomed at $38491.0 in Q2 2024.
  • The 5-year median for Current Leases is $116276.0 (2021), against an average of $98363.3.
  • The largest annual shift saw Current Leases soared 37.92% in 2021 before it tumbled 73.14% in 2024.
  • A 5-year view of Current Leases shows it stood at $119733.0 in 2021, then rose by 12.2% to $134343.0 in 2022, then decreased by 8.64% to $122732.0 in 2023, then crashed by 67.36% to $40057.0 in 2024, then increased by 4.07% to $41686.0 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Current Leases are $41686.0 (Q3 2025), $41686.0 (Q2 2025), and $40863.0 (Q1 2025).